High Diversity of vacA and cagA Helicobacter pylori Genotypes in Patients with and without Gastric Cancer by López-Vidal, Yolanda et al.
High Diversity of vacA and cagA Helicobacter pylori
Genotypes in Patients with and without Gastric Cancer
Yolanda Lo ´pez-Vidal
1*, Sergio Ponce-de-Leo ´n
2, Gonzalo Castillo-Rojas
1, Rafael Barreto-Zu ´n ˜iga
3, Aldo
Torre-Delgadillo
3
1Programa de Inmunologı ´a Molecular Microbiana, Departamento de Microbiologı ´a y Parasitologı ´a, Facultad de Medicina, Universidad Nacional Auto ´noma de Me ´xico
(UNAM), Mexico City, Mexico, 2Unidad de Epidemiologı ´aC l ı ´nica, Instituto Nacional de Ciencias Me ´dicas y Nutricio ´n Salvador Zubira ´n (INCMNSZ), Mexico City, Mexico,
3Departamentos de Endoscopia y Gastroenterologı ´a. Instituto Nacional de Ciencias Me ´dicas y Nutricio ´n Salvador Zubira ´n (INCMNSZ), Mexico City, Mexico
Abstract
Background: Helicobacter pylori is associated with chronic gastritis, peptic ulcers, and gastric cancer. The aim of this study
was to assess the topographical distribution of H. pylori in the stomach as well as the vacA and cagA genotypes in patients
with and without gastric cancer.
Methodology/Principal Findings: Three gastric biopsies, from predetermined regions, were evaluated in 16 patients with
gastric cancer and 14 patients with dyspeptic symptoms. From cancer patients, additional biopsy specimens were obtained
from tumor centers and margins; among these samples, the presence of H. pylori vacA and cagA genotypes was evaluated.
Positive H. pylori was 38% and 26% in biopsies obtained from the gastric cancer and non-cancer groups, respectively
(p=0.008), and 36% in tumor sites. In cancer patients, we found a preferential distribution of H. pylori in the fundus and
corpus, whereas, in the non-cancer group, the distribution was uniform (p=0.003). A majority of the biopsies were
simultaneously cagA gene-positive and -negative. The fundus and corpus demonstrated a higher positivity rate for the cagA
gene in the non-cancer group (p=0.036). A mixture of cagA gene sizes was also significantly more frequent in this group
(p=0.003). Ninety-two percent of all the subjects showed more than one vacA gene genotype; s1b and m1 vacA genotypes
were predominantly found in the gastric cancer group. The highest vacA-genotype signal-sequence diversity was found in
the corpus and 5 cm from tumor margins.
Conclusion/Significance: High H. pylori colonization diversity, along with the cagA gene, was found predominantly in the
fundus and corpus of patients with gastric cancer. The genotype diversity observed across systematic whole-organ and
tumor sampling was remarkable. We find that there is insufficient evidence to support the association of one isolate with a
specific disease, due to the multistrain nature of H. pylori infection shown in this work.
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Introduction
Helicobacter pylori is a gastric pathogen that infects nearly 50% of
the world’s population [1]. It is considered the major etiologic
agent of chronic active gastritis and is generally accepted as the
primary cause of peptic ulcer disease; it is also a known risk factor
for gastric cancer [2]. Gastric cancer development has been
demonstrated to span several decades, beginning sequentially with
H. pylori infection and the development of chronic active gastritis
[3]. Glandular atrophy and intestinal metaplasia eventually occur
in a subset of patients and terminate in gastric cancer [4]. H. pylori
infection has been suggested to lead to an increased relative risk
(RR)—on the order of four to nine-fold—for developing
precancerous gastric conditions, especially when the infection
occurs during childhood [5]. Given that only a minority of H.
pylori-infected individuals develop this disease, it is thought that the
development of disease is dependent on the expression of specific
bacterial virulence genes, for example cagA and vacA [6], both of
which are highly expressed regardless of the disease state of the
host [7,8]. The associations between gastric topography, the
genotypic diversity of the H. pylori vacA and cagA genes, and the
development of gastric cancer remain controversial. The aim of
the present research was to evaluate the distribution of the vacA
and cagA genotypes of H. pylori along the stomach in patients with
and without gastric cancer.
Hypothesis: a higher frequency of H. pylori is associated with
early stages of gastric cancer.
Methods
Patients referred for endoscopic study due to suspicion of cancer
or dyspeptic symptoms were invited to participate in a cross-
sectional prospective study. All patients with cancer were included,
as well as those with non-ulcer dyspepsia and/or gastro-esophageal
reflux. Exclusion criteria included coagulation abnormalities, non-
steroid anti-inflammatory (NSAID) drug intake within the last
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histological study.
All patients signed a written informed consent form prior to
participation in the study. The study protocol was approved by the
Institutional Review Board of the Instituto Nacional de Ciencias
Me ´dicas y Nutricio ´n Salvador Zubira ´n (INCMNSZ), registry
number CIBH-1081.
Upper gastrointestinal endoscopy was performed according to a
standard technique. A systematic biopsy-sampling scheme was used
as follows: from each patient, three gastric biopsies were obtained
from each of the four stomach sites (antrum, angular portion, corpus,
and fundus). From the patients with gastric cancer, additional biopsy
specimens were obtained from the center and margin of the tumor
a n da tad i s t a n c eo fa tl e a s t2 – 5c mf r o mt h et u m o rm a r g i n s .
All pathologic samples from patients with gastric cancer were
evaluated by a single experienced pathologist and classified
according to the Lauren classification as diffuse, intestinal, or
mixed type [9]. The description of advanced gastric cancer was
based on the Borrmann classification [10]. Morphological early
gastric cancer sub-types were classified according to Japanese
Endoscopy Society guidelines [11,12].
H. pylori was cultured by smearing biopsy specimens on the
surface of horse blood agar plates (10% horse blood in Casman agar
base [BBL Microbiology Systems, Cockeysville, MD, USA]) [8].
Chromosomal DNA was extracted [13], and the H. pylori 16S
rRNA and cagA gene was PCR amplified as previously described
[7]. The vacA signal sequence and mid-region were typed by allelic
type-specific PCR, as described previously by Morales et al. [8].
cagA variable region gene amplification. The cagA 39 repeat
regions of the H. pylori strains studied in this investigation were
classified according to their length (due to the presence of a
variable number of repeat sequences in the 39 region of the gene).
The amplification products obtained were categorized by size into
one of three groups: short (906 bp); medium (1,008 bp), and long
(1,110 bp), according to Karita et al. [14]. Amplification was
carried out using primers cagRV17-F 59-acc ctg gtc ggt aat gga tta
tct-39 and cag22-R 59-tta aga ttt ttg gaa acc acc ttt t-39, which were
designed based on sequences retrieved from Genbank using ALIG
(scientific and educational software) and ClustalW (BCM Search
Launcher, multiple sequence alignments).
Data were analyzed for descriptive purposes utilizing relative
frequencies and arithmetic means (standard deviation [SD]), as
deemed appropriate. Comparisons among groups were performed
by x
2 analysis, as well as with Fisher-Freeman-Halton exact test for
contingency tables. The gastric cancer group was compared to
patients with non-ulcer dyspepsia and/or gastroesophageal reflux.
Cancer patients were stratified as early for TNM stage 0, I, or II
and advanced for III or IV. The alpha level was set at 0.05. Given
that multiple simultaneous comparisons were conducted, a
nominal alpha-value correction was introduced following the
Bonferroni procedure. Consequently, we regarded associations
with p values between 0.05 and 0.01 as suspect. In contrast, results
at the p #0.0063 level were considered reasonably significant.
Values between 0.01 and 0.0063 were regarded as marginal. All
analyses were performed using Stata statistical software (Inter-
cooled Stata 7.0 for Windows 98/95/NT Package, 2002) and Stat-
Xact (v. 4.0.1., Cytel Software Corp., 1999).
Results
Thirty-two patients were included in this study. Based on
endoscopic diagnosis, 18 were classified into the gastric cancer
group and 14 into the non-cancer group. Due to histological
evidence of gastric lymphoma, however, two patients in the gastric
cancer group had to be excluded, leaving 16 people in that group.
The average age of the patients in the gastric cancer and dyspeptic
groups was 57.6616.7 years (56% male) and 47.2613.3 years
(14% male), respectively. Ten patients (63%) displayed a diffuse
tumor according to the Lauren classification. Five patients had
early gastric cancer (type I, three; II, one; IIB, one) and 11 had
advanced gastric cancer (type IIIA, four; IIIB, three; IV, four),
according to the Japanese Research Society for Gastric Cancer
guidelines and the Borrmann classification.
In our 411 biopsy samples, H. pylori was identified by either
culture or PCR in 38% (78/203) of the biopsy samples from the
gastric cancer group, 26% (54/208) of the non-cancer group
(p=0.008), and 36% (40/110) of the tumor sites (see Tables 1 and
2). H. pylori demonstrated a differential topographic distribution in
patients with gastric cancer, with a higher positivity rate in the
fundus and corpus (p=0.003), table 1. The non-cancer group
showed no differential topographic distribution. A somewhat
higher positivity of H. pylori was found in the tumor sites by culture
or at tumor margins by PCR; however, these increases in positivity
were not statistically significant (Table 2). There was no significant
correlation between the H. pylori positivity rate and TNM cancer
stage (early vs. late).
We found H. pylori-cagA positivity in 72% of the gastric samples
from the gastric cancer group, 73% of the non-cancer group
(p=NS) (Table 3), and 83% of the tumor sites (p=not significant
[NS]). The H. pylori-cagA topographic distribution was not
statistically significant in the gastric cancer-group, while the non-
cancer group demonstrated a higher positivity rate in the fundus
Table 1. H. pylori positivity distribution in biopsies from patients with or without gastric cancer
Anatomic site Culture P value PCR-16S rRNA P Value Culture+PCR-16S rRNA P value
Non-cancer +
a/
biopsies (%)
Gastric cancer
+
a/biopsies (%)
Non-cancer
+
a/biopsies
b (%)
Gastric cancer
+
a/biopsies
b (%)
Non-cancer
+
a/biopsies (%)
Gastric cancer
+
a/biopsies (%)
Fundus 12/42 (29) 24/42 (57) 1/10 (10) 1/6 (17) 13/52 (25) 25/48 (52) 0.007
Corpus 11/42 (26) 21/42 (50) 3/10 (30) 3/6 (50) 14/52 (27) 24/48 (50) 0.023
Angular portion 12/42 (29) 15/45 (33) 1/10 (10) 3/10 (30) 13/52 (25) 18/55 (33) NS
Antrum 12/42 (29) 9/42 (21) 2/10 (20) 2/10 (20) 14/52 (27) 11/52 (21) NS
Total 47/166 (28) 69/171 (40) 0.022 7/40 (18) 2/10 (20) NS 54/208 (26) 78/203 (38) 0.008
P value NS 0.003 NS NS NS 0.003
aPositivity for Helicobacter pylori;
bpool of three gastric biopsies from each anatomic site that were culture-negative. NS=not significant.
doi:10.1371/journal.pone.0003849.t001
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able (p=0.036) (Table 3). Again, in the tumor sites, we found no
significant distribution pattern for the cagA positivity fraction, nor
was there a difference between patients with early and advanced
gastric cancer.
Eighty-one H. pylori strains were studied (80 cagA +), including
46 strains from patients with gastric cancer and 35 from non-
cancer patients. Only two cagA gene sizes were obtained from the
80 H. pylori strains studied; none of the longer cagA sequences were
found. In both groups, the shorter cagA was the most frequently
detected. The results are summarized in Table 4. Interestingly,
both cagA sizes were amplified from 12 (15%) strains, suggesting
that these patients were co-infected with multiple H. pylori strains.
This finding was obtained more often in the non-cancer patient
group (28.6%) than in the gastric cancer group (4.4%) (p=0.003).
The predominant signal sequence genotype in patients with
gastric cancer, present in 39% of the group, was s1b. The s1b/s2
combination was present in 20% of the group and s2 was present
in 12%. Sixteen percent of patients with gastric cancer had an
unidentifiable signal sequence (s0). There was no statistically
significant distribution of vacA genotypes across the stomach
(p=NS) (see Figure 1). The most frequent vacA genotype in the
non-cancer group was s1b, which was present in 59% of the
group, followed by the s1a/s1b combination in 11%, s1a/s1b/s2
in 7%, and an unidentifiable signal sequence in 9% (p=0.06),
Figure 1. Analysis of the topographic genotype distribution showed
that genotype s1b of vacA was predominant in all zones (fundus,
corpus, angular portion, and antrum) of the stomach in both
groups studied (Figure S1). We found a distinct and marginally
significant difference in the distribution patterns of these genotypes
between the cancer and non-cancer groups (p=0.01). Both the
corpus and fundus of the gastric cancer group exhibited a greater
diversity of signal-sequence genotypes, as did the corpus in the
non-cancer group (Figure S1).
The most frequent vacA genotypes for each of the tumor sites
(center and margin of the tumor, and at least 2–5 cm from the
tumor margins) were s1b and s2, which were present in 19%; s1a/
s1b and s1b/s2 were each present in 17%, and s1a/s1b/2, s1a/s2,
and s0 were present in 8%. There was no significant association
between the genotype and tumor site proximity (Figure 2). The
distribution of this genotype in tumor and anatomic sites in
patients with cancer was not statistically significant (p=0.06)
(Figures 1 and 2). A significant association (p=0.02) between
genotype and tumor stage was identified: s1a/s1b, s1a/s1b/s2,
and s1b/s2 genotypes were predominant in the early gastric
cancer group, whereas s1b, s2, and s1a/s2 genotypes were
relatively abundant in the advanced gastric cancer group
(Figure 3).
The most frequent mid-region genotype in patients with gastric
cancer was m1, which was present in 44% of the patients, followed
by m0 (untypeable genotype) in 26%, m2 in 21%, and the m1/m2
combination in 10% (Figure 1). In the non-cancer group, the most
frequent vacA genotype was m1, which was present in 52% of the
patients, followed by m0 in 32%, the m1/m2 combination in 11%,
Table 3. H. pylori cagA-positive distribution in biopsies from
patients with or without gastric cancer
Anatomic site H. pylori cagA
a
P value
Non-cancer +
a/
biopsies (%)
Gastric cancer +
a/
biopsies (%)
Fundus 12/13 (92) 17/25 (68) NS
Corpus 14/16 (88) 17/26 (65) NS
Angular portion 8/13 (62) 14/18 (78) NS
Antrum 7/14 (50) 11/13 (85) NS
Total 41/56 (73) 59/82 (72) NS
P value 0.036 NS
aOnly strains and biopsies samples that were positive (primary culture) for H.
pylori based on 16S ribosomal RNA PCR were considered. NS=not significant.
doi:10.1371/journal.pone.0003849.t003
Table 4. cagA size variation in H. pylori strains isolated from
gastric cancer and non-cancer patient groups*
PCR fragment
Non-cancer group
n=35(%)
Gastric cancer
group n=46(%)
906 bp 1,008 bp
Absence Absence 0 1 (2.17)
Absence Presence 9 (25.71) 8 (17.39)
Presence Absence 16 (45.71) 35 (76.09)
Presence Presence 10 (28.57) 2 (4.35)
*Cancer vs Non-cancer groups Fisher’s exact test P=0.003.
doi:10.1371/journal.pone.0003849.t004
Table 2. H. pylori positivity distribution in biopsies from tumor sites of patients with early or advanced gastric cancer
Anatomic site Culture +
a/biopsies (%) PCR-16S rRNA +
a/biopsies
b (%) Culture+PCR-16S rRNA +
a/biopsies (%)
Mid-tumor 5/16 (31) 5/12 (42) 10/28 (36)
Tumor margin 6/16 (38) 6/11 (55) 12/27 (44)
At least 2 cm** 6/16 (38) 3/11 (27) 9/27 (33)
At least 5 cm** 5/16 (31) 4/12 (33) 9/28 (32)
Total 22/64 (34) 18/46 (39) 40/110 (36)
P value NS NS NS
P value (trend) NS NS NS
P value (early vs. advanced) NS NS NS
aPositivity for Helicobacter pylori;
bgastric biopsies that were culture-negative.
**At least 2 and 5 cm away from the tumor margin. NS=not significant.
doi:10.1371/journal.pone.0003849.t002
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genotypes, with a questionable significance level (p=0.03)
(Figure 1). Analysis of the topographic distribution across anatomic
zones of the mid-region genotype showed that the m1 genotype
was predominantly (50%) in the angular portion, with the
remaining in the fundus (48%) and the corpus (42%). The m0
genotype was predominantly in the antrum (39%) in the gastric
cancer group (Figure S1). In the non-cancer group, the m1
Figure 1. Signal sequence and middle region allele of the vacA gene obtained from patients with and without gastric cancer.
doi:10.1371/journal.pone.0003849.g001
Figure 2. Signal sequence and middle region allele distribution of the vacA gene in the tumor site.
doi:10.1371/journal.pone.0003849.g002
Figure 3. Signal sequence and middle region allele distribution of the vacA gene in the tumor site of patients with early and
advanced gastric cancer.
doi:10.1371/journal.pone.0003849.g003
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corpus, and 43% was in the antrum. The m0 genotype was
detected in the angular portion (62%), with no statistically
significant difference between study groups (Figure S1). A nearly
uniform distribution of the different genotypes was found in the
tumor sites, (Figure 2). There was no difference between anatomic
zones and tumor sites in patients with gastric cancer (Figure 1 and
2) or between early and advanced tumors (Figure 3).
Table 5 shows the analysis of the distinct vacA genotypes found
within each individual for whom more than one biopsy was
studied. Ninety-two percent (12/13) of the cancer patients had
more than one genotype present. A similar finding was observed in
the non-cancer group. Three subjects in the non-cancer group
were consistently positive for the cagA gene, and another three
possessed both types (positive and negative) simultaneously. In the
cancer group, six individuals were positive for cagA and seven for
both types. No subjects were consistently negative for this gene.
Figure 4 displays the number of biopsies per individual and the
number of distinct vacA gene signal segment (SS) genotypes. The
lowest number of genotypes in patients with 10 or more biopsies
was two, and the highest was five.
Discussion
The present study resulted in four major findings: first, H. pylori
is uniformly distributed across the stomach in patients having only
dyspeptic symptoms; second, H. pylori has a preference for the
fundus and the corpus in patients with gastric cancer; third, in
patients with dyspeptic symptoms, H. pylori-cagA has a preferential
distribution in the fundus and corpus and there is a high frequency
of mixed cagA sizes; fourth, the s1b genotype was predominant in
both study groups, and the s1a genotype was present only in the
dyspeptic group.
The high H. pylori positivity in the fundus of patients with gastric
cancer may have been due to its proximity to the corpus, a zone
that is colonized in H. pylori-induced gastritis. Corpus-predominant
atrophy, or the loss of specialized glandular cell types such as
parietal and chief cells, appears to be critical for cancer
progression [15], and it is likely that the fundus is involved either
before or after the corpus is already engaged in cancer.
A relatively high positivity for H. pylori was found at the tumor-
site despite prior statements that H. pylori cannot develop in
atrophied mucosa and that the intestinal metaplasia is an
unfavorable milieu [16]. Tang et al., however, suggested that H.
pylori might survive in the gastric epithelium in the presence of a
carcinogenic lesion [17]. It has also been speculated that certain
Figure 4. Distinct genotype number (numgeno) of the vacA
gene signal segment according to the total number of biopsies
(numbx) obtained from subjects exhibiting the presence of H.
pylori present and with and without cancer (C=cancer group;
N=non-cancer group).
doi:10.1371/journal.pone.0003849.g004
Table 5. Variability in the vacA genotypes (SS and MR regions) per subject across the entire biopsy sampling scheme for the
stomach in patients who were positive for H. pylori and had at least two analyzable biopsies (maximum=16 gastric cancer patients
and 12 non-cancer subjects)
vacA genotypes
Signal sequence Mid-region
Number of distinct
genotypes per subject Number of subjects
Number of distinct genotypes
per subject Number of subjects
Gastric cancer group 1 1 1 1
232 6
343 5
414 1
54- -
6-8 0 - -
TOTAL 13 TOTAL 13
Non-cancer group 1 0 1 1
222 3
303 0
424 2
51- -
6–8 0 - -
TOTAL 5 TOTAL 6
doi:10.1371/journal.pone.0003849.t005
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pylori in the gastric mucosa [18].
In the present study, we observed that H. pylori demonstrates
similar colonization of the anatomic regions of the stomach and
tumor site. H. pylori positivity in early and advanced gastric cancer
groups was also found to be very similar; Tang et al., however,
observed the inverse results [17]. We believe that the difference
observed between these two studies is due to the number of
biopsies studied in each patient; we demonstrated that systematic
sampling modifies the association of H. pylori with illness.
A higher prevalence of H. pylori cagA gene-positivity was found in
the corpus and fundus of patients with dyspepsia. Previously,
Semino-Mora et al. showed that this pattern is not present in
patients with gastric cancer [19], although we used a different cagA
amplification fragment in the present work. Gastric neoplastic
transformation is induced and sustained, at least in part, by in vivo
intracellular cagA expression; this effect could play a role not only
during early gastric carcinogenesis but, based on our data, could
also occur later in this process [19]. We observed that 15% of the
strains possessed a mixture of cagA 39 repeat region sizes,
suggesting the presence of co-infection with multiple H. pylori
strains, mainly in the non-cancer group. Kidd et al. obtained
different results; while these authors studied a higher number of
patients [20], we studied a higher number of gastric biopsies of
which included several specific sites within the stomach.
We previously observed the presence of genotypic diversity in the
peptic ulcer corpus [8]. This diversity has been proposed to reflect
the synergistic actions that are associated with this process [21]. The
predominant vacA genotype signal sequence detected in both study
groups was s1b, in agreement with our previous report [22].
The important findings of our study are that there is a
topographic distribution of the vacA signal-sequence, the s1b
genotype is commonly associated with the non-cancer group and
the s1b/s2 combination or s2 genotypes are found solely in the
gastric cancer group. No previous studies on individuals with
gastric cancer have considered the four tumor zones evaluated in
the present work. The s1c genotype was found to be the most
prevalent genotype in Asia; however, its association with gastric
cancer is diminishing [22,23]. The diversity of the vacA genotype of
H. pylori has been explained by a co-evolution model [21].
Regarding vacA mid-region alleles, we found m1 and m2
genotypes, in both studied groups, with m1 genotype being the
most frequent in the predetermined regions of the evaluated
stomach [8].
In both studied groups, we found H. pylori strains that were
untypeable for the signal-sequence and mid-region alleles due to
significant variation in the vacA gene [8,24]. We consistently found
that the cagA- and vacA-allele diversity was greater in the tumor,
suggesting that H. pylori can remain in the tumor without
environmental stress.
The genotypic diversity observed across systematic whole
organs and tumors in the present work was remarkable. The
principal practical implication of this finding is the need to search
for a similar exhaustive sampling scheme in order to associate a
pathogenicity factor with disease. We found that the association of
a single isolate—derived from a single biopsy—with disease is not
sufficient due to the multistrain nature of H. pylori infection
demonstrated in the present work.
The limitations of this study are related to its observational
nature and its cross-sectional design. We cannot exclude the
possibility that there is a confounding variable associated both with
the presence of the Helicobacter pylori infection and the cancer or
dyspeptic status. In addition, the lack of a longitudinal follow-up
prevents us from confirming the sequential appearance of the
events, like cancer development and the initial infection with the
strain(s) of Helicobacter pylori that were eventually detected.
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